Oral candidiasis secondary prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 4: Line 4:
==Overview==
==Overview==
Candida is usually a self limiting disease unless concurrent immunosuppression is present.
Candida is usually a self limiting disease unless concurrent immunosuppression is present.
==Secondary prevention==
==Secondary prevention==
*Proper treatment of candididiasis using topical agents is usually enough for controlling symptoms.
*Proper treatment of candididiasis using topical agents is usually enough for controlling symptoms.
*In immunocompromised patients, prophylactic fluconazole is effective in reducing recurrences.<ref name="pmid19191635">{{cite journal| author=Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF, Edwards JE et al.| title=Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. | journal=Clin Infect Dis | year= 2009 | volume= 48 | issue= 5 | pages= 503-35 | pmid=19191635 | doi=10.1086/596757 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19191635  }} </ref>
*In immunocompromised patients, prophylactic fluconazole is effective in reducing recurrences.<ref name="pmid19191635">{{cite journal| author=Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF, Edwards JE et al.| title=Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. | journal=Clin Infect Dis | year= 2009 | volume= 48 | issue= 5 | pages= 503-35 | pmid=19191635 | doi=10.1086/596757 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19191635  }} </ref>
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 16:51, 10 May 2017

Oral candidiasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Oral candidiasis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Oral candidiasis secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Oral candidiasis secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Oral candidiasis secondary prevention

CDC on Oral candidiasis secondary prevention

Oral candidiasis secondary prevention in the news

Blogs on Oral candidiasis secondary prevention

Directions to Hospitals Treating Oral candidiasis

Risk calculators and risk factors for Oral candidiasis secondary prevention

Overview

Candida is usually a self limiting disease unless concurrent immunosuppression is present.

Secondary prevention

  • Proper treatment of candididiasis using topical agents is usually enough for controlling symptoms.
  • In immunocompromised patients, prophylactic fluconazole is effective in reducing recurrences.[1]

References

  1. Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF, Edwards JE; et al. (2009). "Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America". Clin Infect Dis. 48 (5): 503–35. doi:10.1086/596757. PMID 19191635.

Template:WH Template:WS